142 related articles for article (PubMed ID: 9196133)
1. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
Uckun FM; Gaynon PS; Sensel MG; Nachman J; Trigg ME; Steinherz PG; Hutchinson R; Bostrom BC; Sather HN; Reaman GH
J Clin Oncol; 1997 Jun; 15(6):2214-21. PubMed ID: 9196133
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Gaynon P; Sather H; Arthur D; Trigg M; Tubergen D; Nachman J; Steinherz P; Sensel MG; Reaman GR
Blood; 1997 Apr; 89(7):2488-93. PubMed ID: 9116293
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather HN; Gaynon PS; Arthur DC; Trigg ME; Tubergen DG; Nachman J; Steinherz PG; Sensel MG; Reaman GH
Blood; 1997 Jul; 90(1):28-35. PubMed ID: 9207434
[TBL] [Abstract][Full Text] [Related]
6. CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Steinherz PG; Sather H; Trigg M; Arthur D; Tubergen D; Gaynon P; Reaman G
Blood; 1996 Dec; 88(11):4288-95. PubMed ID: 8943865
[TBL] [Abstract][Full Text] [Related]
7. [Phenotypic analysis of immature T-lineage cells].
Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
Rinsho Byori; 1993 Sep; 41(9):966-75. PubMed ID: 8254974
[TBL] [Abstract][Full Text] [Related]
8. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
Uckun FM; Sensel MG; Sather HN; Gaynon PS; Arthur DC; Lange BJ; Steinherz PG; Kraft P; Hutchinson R; Nachman JB; Reaman GH; Heerema NA
J Clin Oncol; 1998 Feb; 16(2):527-35. PubMed ID: 9469337
[TBL] [Abstract][Full Text] [Related]
10. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
11. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of chromosome analysis in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group (CCLSG)].
Hyakuna N; Kaneko Y; Katano N; Iwai T; Nagata T; Sakashita K; Takeda O; Tanaka A; Azuma H; Sekine I; Fujimoto T
Rinsho Ketsueki; 2000 Jul; 41(7):576-84. PubMed ID: 11020981
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern of CD45 RA/RO isoformic antigens in T-lineage neoplasms.
Kawano S; Tatsumi E; Yoneda N; Tani A; Nakamura F
Am J Hematol; 1995 May; 49(1):6-14. PubMed ID: 7741140
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Heerema NA; Sather HN; Sensel MG; Kraft P; Nachman JB; Steinherz PG; Lange BJ; Hutchinson RS; Reaman GH; Trigg ME; Arthur DC; Gaynon PS; Uckun FM
J Clin Oncol; 1998 Apr; 16(4):1270-8. PubMed ID: 9552025
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
[TBL] [Abstract][Full Text] [Related]
18. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases.
Rozenova KA; Jevremovic D; Reichard KK; Nguyen P; Otteson GE; Timm MM; Horna P; Olteanu H; Shi M
Hum Pathol; 2021 Aug; 114():66-73. PubMed ID: 34019867
[TBL] [Abstract][Full Text] [Related]
19. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
